Alliance Highlights Six Active Clinical Trials Focusing on Lung Cancer

As lung cancer is the third most common cancer in the U.S., Alliance works to offer treatment and prevention studies to impact this statistic. Lung cancer is caused by an unchecked growth of cells in a person’s lungs. It typically starts in the cells lining the bronchi and parts of the lung such as the bronchioles or alveoli. In general, about 13 percent of all lung cancers are small cell lung cancer, and 84 percent are non-small cell lung cancer. Treatment for lung cancer includes surg


2023 Fall Hybrid Group Meeting
- November 1-4, 2023 | Register | Schedule

2024 Spring Hybrid Group Meeting
- May 15-18, 2024

2024 Fall Hybrid Group Meeting
- October 30-November 2, 2024

All meetings are open to all
Alliance members.